The Patent Finder

Terms ending in 2032

Chemocentryx, Inc.

Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,139,526Polymorphic Forms of the Sodium Salt of 4-TERT-BUTYL-N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENESULFONAMIDE
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,150,513Polymorphic Forms of the Sodium Salt of 4-TERT- Butyl -N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENE Sulfonamide
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,464,054Polymorphic Forms of the Sodium Salt of 4-TERT-BUTYL-N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENESULFONAMIDE
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,493,417Polymorphic Forms of the Sodium Salt of 4-TERT-BUTYL-N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENESULFONAMIDE
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,809,548Polymorphic Forms of the Sodium Salt of 4-TERT- Butyl -N-[4-Chloro-2-(1-OXY-PYRIDINE-4-Carbonyl)-PHENYL]-BENZENE Sulfonamide
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 8,685,959Substituted Benzimidazoles and Benzopyrazoles as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,150,550Substituted Benzimidazoles and Benzopyrazoles as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,567,323Substituted Anilines as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,758,512Substituted Anilines as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 9,790,204Substituted Benzimidazoles and Benzopyrazoles as CCR(4) Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
4 more term ends in 2032 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited